H Wallaschofski

Summary

Affiliation: University of Erlangen-Nuremberg
Country: Germany

Publications

  1. ncbi request reprint Distinction between autoimmune and non-autoimmune hyperthyroidism by determination of TSH-receptor antibodies in patients with the initial diagnosis of toxic multinodular goiter
    H Wallaschofski
    Department of Nuclear Medicine, University of Liepzig, 04103 Liepzig, Germany
    Horm Metab Res 33:504-7. 2001
  2. ncbi request reprint TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre
    H Wallaschofski
    Department of Internal Medicine I, Friedrich Alexander University of Erlangen Nurnberg, Germany
    Exp Clin Endocrinol Diabetes 112:171-4. 2004
  3. ncbi request reprint Differences in platelet activation by prolactin and leptin
    H Wallaschofski
    Department of Internal Medicine I, University of Erlangen, Ulmenweg 18, 91054 Erlangen, Germany
    Horm Metab Res 36:453-7. 2004
  4. ncbi request reprint Co-activation of platelets by prolactin or leptin--pathophysiological findings and clinical implications
    H Wallaschofski
    Department of Internal Medicine I, University of Erlangen, Germany
    Horm Metab Res 36:1-6. 2004
  5. ncbi request reprint Prolactin receptor signaling during platelet activation
    H Wallaschofski
    Department of Internal Medicine I, University of Erlangen, Germany
    Horm Metab Res 35:228-35. 2003
  6. ncbi request reprint Increased prolactin in acute coronary syndromes as putative Co-activator of ADP-stimulated P-selectin expression
    D Raaz
    Medical Clinic 2, University Hospital Erlangen, Germany
    Horm Metab Res 38:767-72. 2006
  7. ncbi request reprint Adiponectin in patients with obstructive sleep apnea syndrome: course and physiological relevance
    I A Harsch
    Medical Department I, Friedrich Alexander University of Erlangen Nuremberg, Erlangen, Germany
    Respiration 71:580-6. 2004
  8. doi request reprint Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients
    J Kreutzer
    Department of Neurosurgery, University of Erlangen Nuremberg, Schwabachanlage 6, 91054 Erlangen, Germany
    Eur J Endocrinol 158:11-8. 2008
  9. doi request reprint Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study
    M Buchfelder
    Department of Neurosurgery, University of Erlangen Nurnberg, Schwabachanlage 6, 91054 Erlangen, Germany
    Eur J Endocrinol 161:27-35. 2009
  10. ncbi request reprint Prediction of remission or relapse for Graves' hyperthyroidism by the combined determination of stimulating, blocking and binding TSH-receptor antibodies after the withdrawal of antithyroid drug treatment
    H Wallaschofski
    Department of Internal Medicine III, University of Leipzig, Germany
    Horm Metab Res 34:383-8. 2002

Detail Information

Publications17

  1. ncbi request reprint Distinction between autoimmune and non-autoimmune hyperthyroidism by determination of TSH-receptor antibodies in patients with the initial diagnosis of toxic multinodular goiter
    H Wallaschofski
    Department of Nuclear Medicine, University of Liepzig, 04103 Liepzig, Germany
    Horm Metab Res 33:504-7. 2001
    ....
  2. ncbi request reprint TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre
    H Wallaschofski
    Department of Internal Medicine I, Friedrich Alexander University of Erlangen Nurnberg, Germany
    Exp Clin Endocrinol Diabetes 112:171-4. 2004
    ....
  3. ncbi request reprint Differences in platelet activation by prolactin and leptin
    H Wallaschofski
    Department of Internal Medicine I, University of Erlangen, Ulmenweg 18, 91054 Erlangen, Germany
    Horm Metab Res 36:453-7. 2004
    ..Moreover, our data suggest that the stronger effect of prolactin on ADP-stimulated platelet aggregation, compared to leptin, depends on higher stimulation of CD62p expression by prolactin...
  4. ncbi request reprint Co-activation of platelets by prolactin or leptin--pathophysiological findings and clinical implications
    H Wallaschofski
    Department of Internal Medicine I, University of Erlangen, Germany
    Horm Metab Res 36:1-6. 2004
    ....
  5. ncbi request reprint Prolactin receptor signaling during platelet activation
    H Wallaschofski
    Department of Internal Medicine I, University of Erlangen, Germany
    Horm Metab Res 35:228-35. 2003
    ..Revealing the molecular mechanisms of prolactin signaling will allow the design of new antithrombotic therapies...
  6. ncbi request reprint Increased prolactin in acute coronary syndromes as putative Co-activator of ADP-stimulated P-selectin expression
    D Raaz
    Medical Clinic 2, University Hospital Erlangen, Germany
    Horm Metab Res 38:767-72. 2006
    ..Therefore, the stress hormone prolactin could be a co-stimulator of platelet activation in these patients. In contrast, the putative platelet activator leptin does not seem to play a major role in acute coronary syndromes...
  7. ncbi request reprint Adiponectin in patients with obstructive sleep apnea syndrome: course and physiological relevance
    I A Harsch
    Medical Department I, Friedrich Alexander University of Erlangen Nuremberg, Erlangen, Germany
    Respiration 71:580-6. 2004
    ..Adiponectin is an adipocyte-derived hormone with anti-inflammatory and insulin-sensitizing properties. Insulin resistance is a typical feature of the obstructive sleep apnea syndrome (OSAS)...
  8. doi request reprint Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients
    J Kreutzer
    Department of Neurosurgery, University of Erlangen Nuremberg, Schwabachanlage 6, 91054 Erlangen, Germany
    Eur J Endocrinol 158:11-8. 2008
    ..Classical' surgical indications are intolerance or lack of efficiency of DA therapy. Focusing on a possible shift of recent indications, we retrospectively analyzed our results of surgical treatment in prolactinomas...
  9. doi request reprint Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study
    M Buchfelder
    Department of Neurosurgery, University of Erlangen Nurnberg, Schwabachanlage 6, 91054 Erlangen, Germany
    Eur J Endocrinol 161:27-35. 2009
    ..Although these data are reassuring with regard to the concern of somatotroph adenoma growth under peripheral GH receptor blockade, further study is required...
  10. ncbi request reprint Prediction of remission or relapse for Graves' hyperthyroidism by the combined determination of stimulating, blocking and binding TSH-receptor antibodies after the withdrawal of antithyroid drug treatment
    H Wallaschofski
    Department of Internal Medicine III, University of Leipzig, Germany
    Horm Metab Res 34:383-8. 2002
    ..Consequently, our results suggest that the prediction of the individual course of GD can only be improved by combined determinations of all TRAb qualities (hTBII, TSAbs and TSBAbs) after the end of ATDT...
  11. ncbi request reprint PRL as a novel potent cofactor for platelet aggregation
    H Wallaschofski
    Department of Internal Medicine III, University of Leipzig, Germany
    J Clin Endocrinol Metab 86:5912-9. 2001
    ..Further studies of the interaction between PRL and platelets will clarify the clinical relevance of hyperprolactinemia as a potential risk factor for VTE...
  12. ncbi request reprint Lack of relevant association between prolactin and immune responses in patients with chronic heart failure
    H Wallaschofski
    Eur J Clin Invest 33:1018; author reply 1019. 2003
  13. ncbi request reprint Pre-eclampsia as a 'three stage problem'--a workshop report
    H Stepan
    Department of Obstetrics and Gynecology, University of Leipzig, Philipp Rosenthalstr 55, 04103, Leipzig, Germany
    Placenta 25:585-7. 2004
  14. ncbi request reprint HLA-DQA1*0301-associated susceptibility for autoimmune polyglandular syndrome type II and III
    H Wallaschofski
    Department of Internal Medicine II, Klinikum Erfurt GmbH, Erlangen, Germany
    Horm Metab Res 35:120-4. 2003
    ..Moreover, our data imply that the allele DQA1*0301 is a marker of increased risk for further APS manifestations in patients who suffer from an organ-specific autoimmune disease...
  15. ncbi request reprint [Treatment of proven growth hormone deficiency in adults with recombinant human growth hormone according to evidence-based criteria]
    W J Fassbender
    Hospital zum Hl Geist Kempen, Akad Lehrkrankenhaus der Universität Düsseldorf, Innere Abteilung, Kempen Ndrh
    Dtsch Med Wochenschr 130:2589-95. 2005
  16. ncbi request reprint Induction of TSH-receptor antibodies in patients with toxic multinodular goitre by radioiodine treatment
    H Wallaschofski
    Department of Nuclear Medicine, University of Leipzig, Phillip Rosenthal Strasse 27, 04103 Leipzig, Germany
    Horm Metab Res 34:36-9. 2002
    ..These patients therefore require more frequent evaluation after RAI treatment...
  17. ncbi request reprint Normal levels of serum IGF-I: determinants and validity of current reference ranges
    G Brabant
    Department of Endocrinology, Christie Hospital, Wilmslow Rd, Manchester M20 4BX, UK
    Pituitary 10:129-33. 2007
    ..Even though reference ranges have been developed in large cohorts of healthy subjects, the dependency of these data on a given assay technology argues for assay specific normative data for IGF-I...